Cargando…
Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts
The human breast cancer cell line (MCF7) was established as xenografts in intact female nude mice. Xenografts did not require oestrogen supplementation for growth, although oestrogen supplementation caused more rapid tumour growth. GnRH Pharmaccine is an immunogen composed of gonadotrophin releasing...
Autores principales: | Jacobs, E, Watson, S A, Michaeli, D, Ellis, I O, Robertson, J F R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362318/ https://www.ncbi.nlm.nih.gov/pubmed/10408837 http://dx.doi.org/10.1038/sj.bjc.6690362 |
Ejemplares similares
-
Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008) -
Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
por: Xia, Min, et al.
Publicado: (2021) -
Research Note: Polymorphisms of gonadotrophin-releasing hormone gene and their association with growth traits in quail (Coturnix Coturnix)
por: Wang, Xinle, et al.
Publicado: (2022) -
The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles
por: Chen, Li, et al.
Publicado: (2023) -
Using automated imaging to interrogate gonadotrophin-releasing hormone receptor trafficking and function
por: Armstrong, S.P., et al.
Publicado: (2011)